Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Cardiotoxicity”

103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 103 results

Not applicableStudy completedNCT00636844
What this trial is testing

Detection of Chemotherapy Induced Cardiotoxicity

Who this might be right for
Cancer
George Washington University 36
Not applicableStudy completedNCT05676606
What this trial is testing

Cardiotoxicity Monitoring With Single-lead Electrocardiogram

Who this might be right for
Cardiotoxicity
I.M. Sechenov First Moscow State Medical University 120
Testing effectiveness (Phase 2)UnknownNCT03785704
What this trial is testing

Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast NeoplasmsCardiac EventChemotherapeutic Toxicity
Peking Union Medical College 60
Not applicableStudy completedNCT07515859
What this trial is testing

Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

Who this might be right for
Cancer Therapy-Related Cardiac DysfunctionHeart FailureLeft Ventricular Dysfunction
Yonsei University 31,486
Not applicableEnrolling By InvitationNCT05913999
What this trial is testing

Serial PET MPI in Patients Undergoing Cancer Treatment

Who this might be right for
CancerChemotherapeutic ToxicityCoronary Artery Disease+1 more
University of California, Los Angeles 60
Testing effectiveness (Phase 2)Ended earlyNCT00019864
What this trial is testing

Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma

Who this might be right for
Cardiac ToxicitySarcoma
National Cancer Institute (NCI) 100
Not applicableLooking for participantsNCT06622954
What this trial is testing

Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients

Who this might be right for
CardiotoxicityBreast Cancer
Erasmus Medical Center 32
Large-scale testing (Phase 3)Looking for participantsNCT06214195
What this trial is testing

The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity

Who this might be right for
Cardiotoxicity Induced by Drug Therapy for Breast Cancer
Zhejiang Cancer Hospital 276
Large-scale testing (Phase 3)UnknownNCT01093235
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Who this might be right for
Breast CancerCardiac ToxicityPerioperative/Postoperative Complications
Cambridge University Hospitals NHS Foundation Trust 800
Not applicableUnknownNCT03650205
What this trial is testing

Ivabradine to Prevent Anthracycline-induced Cardiotoxicity

Who this might be right for
NeoplasmsHeart FailureCardiotoxicity+2 more
University of Sao Paulo 160
Large-scale testing (Phase 3)Study completedNCT03265574
What this trial is testing

PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?

Who this might be right for
Breast CancerNon Hodgkin Lymphoma
South Tees Hospitals NHS Foundation Trust 111
Not applicableUnknownNCT05159479
What this trial is testing

Defining Robust Predictors of Chemotherapy Related Cardiotoxicity

Who this might be right for
CardiotoxicityGastrointestinal Neoplasms
University College, London 600
Post-approval studies (Phase 4)UnknownNCT06005259
What this trial is testing

Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)

Who this might be right for
CardiotoxicityNeoplasmsChemotherapy Effect+1 more
University of Sao Paulo 264
Testing effectiveness (Phase 2)Ended earlyNCT01120171
What this trial is testing

Myocet Plus Endoxan for Older Patients With Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 64
Not applicableUnknownNCT05992337
What this trial is testing

New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.

Who this might be right for
CardiotoxicityChemotherapy EffectChemotherapy Induced Systolic Dysfunction
Cardiology Prague 200
Not applicableStudy completedNCT02274480
What this trial is testing

Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity

Who this might be right for
Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients
Memorial Sloan Kettering Cancer Center 28
Not applicableUnknownNCT03301389
What this trial is testing

Cardiac Magnetic Resonance for Early Detection of Chemotherapy or Radiation Therapy Induced Cardiotoxicity in Breast Cancer (CareBest)

Who this might be right for
Chemotherapy Induced Cardiotoxicity
Yonsei University 2,000
Large-scale testing (Phase 3)Study completedNCT00002827
What this trial is testing

Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease

Who this might be right for
Cardiac ToxicityLymphoma
Children's Oncology Group 294
Not applicableWithdrawnNCT02130934
What this trial is testing

Cardiac 3D MRI in Pediatric Cancer Patients

Who this might be right for
Childhood Cancer
Majd Makhoul
Not applicableUnknownNCT01032278
What this trial is testing

Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

Who this might be right for
Cardiac ToxicityUnspecified Adult Solid Tumor, Protocol Specific
M.D. Anderson Cancer Center 597
Load More Results